Skip to main content

Table 1 Demographic data of the patients.

From: Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

 

QT (n = 54)

OAR (n = 45)

P value

Age

46.4

48.6

ns

Sex (male/female)

25/29

23/22

ns

Caucasian

96.3%

97.7%

 

Endoscopic findings

   

Chronic gastritis

25 (46.3%)

28 (62.2%)

 

GD Ulcer

29 (53.7%)

17 (37.8%)

ns

Smokers

12 (22.2%)

10 (22.2%)

ns

Alcohol consumers

15 (27.8%)

11 (24.4%)

ns

ASA/NSAID

10 (18.5%)

2 (4.4%)

0.031

  1. GD Ulcer: Gastroduodenal ulcer
  2. Smokers ≥ 10 cigarettes per day
  3. Alcohol consumers ≥ 2 units per day
  4. ns: no significant
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us